AA

ALPS Advisors Portfolio holdings

AUM $21.3B
1-Year Est. Return 21.71%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+21.71%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$17.2B
AUM Growth
-$788M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
1,092
New
Increased
Reduced
Closed

Top Buys

1
+$103M
2
+$42.8M
3
+$40.5M
4
HESM icon
Hess Midstream
HESM
+$33.9M
5
AG icon
First Majestic Silver
AG
+$33.6M

Top Sells

1
+$1.35B
2
+$86.3M
3
+$55.9M
4
MA icon
Mastercard
MA
+$42.6M
5
NEM icon
Newmont
NEM
+$36M

Sector Composition

1 Energy 62.96%
2 Materials 5.89%
3 Technology 4.09%
4 Financials 3.1%
5 Consumer Discretionary 3.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RZLT icon
1001
Rezolute
RZLT
$307M
$180K ﹤0.01%
76,143
+33,247
ARCT icon
1002
Arcturus Therapeutics
ARCT
$262M
$143K ﹤0.01%
23,325
+10,224
FNUC
1003
Frontier Nuclear and Minerals Inc
FNUC
$54.5M
$105K ﹤0.01%
+35,054
GORO icon
1004
Gold Resource Corp
GORO
$212M
$105K ﹤0.01%
+126,738
ATLX icon
1005
Atlas Lithium Corp
ATLX
$179M
$99K ﹤0.01%
23,413
+11,447
WWR icon
1006
Westwater Resources
WWR
$82.9M
$89.4K ﹤0.01%
+119,180
RC
1007
Ready Capital
RC
$312M
$80.7K ﹤0.01%
37,002
SITC icon
1008
SITE Centers
SITC
$291M
$65.8K ﹤0.01%
10,243
TRVI icon
1009
Trevi Therapeutics
TRVI
$2.06B
– –
-58,292
TRML
1010
DELISTED
Tourmaline Bio
TRML
– –
-12,465
TERN
1011
DELISTED
Terns Pharmaceuticals
TERN
– –
-42,630
SWK icon
1012
Stanley Black & Decker
SWK
$12.6B
– –
-316,258
ACLX
1013
DELISTED
Arcellx
ACLX
– –
-25,188
ADM icon
1014
Archer Daniels Midland
ADM
$37.4B
– –
-398,432
AKRO
1015
DELISTED
Akero Therapeutics
AKRO
– –
-37,356
ALE
1016
DELISTED
Allete
ALE
– –
-27,950
ANAB icon
1017
AnaptysBio
ANAB
$2.02B
– –
-13,335
ANNX icon
1018
Annexon
ANNX
$925M
– –
-47,879
AON icon
1019
Aon
AON
$66.8B
– –
-966
ARIS
1020
DELISTED
Aris Water Solutions
ARIS
– –
-63,478
ARWR icon
1021
Arrowhead Research
ARWR
$10.2B
– –
-65,204
AUPH icon
1022
Aurinia Pharmaceuticals
AUPH
$1.98B
– –
-61,065
AUTL
1023
Autolus Therapeutics
AUTL
$418M
– –
-124,606
AXSM icon
1024
Axsome Therapeutics
AXSM
$11.2B
– –
-24,437
BCRX icon
1025
BioCryst Pharmaceuticals
BCRX
$2.19B
– –
-101,125
39 40
41
42 43